pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,349 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 0 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: grant×type: approval×clear all
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

49
›RECRUITINGphase readoutNCT07402109: CBCT Guided Markerless SBRT for Renal Cell Cancer

Sponsor: Erasmus Medical Center. Phase: NA. Conditions: Renal Cell Carcinoma (RCC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07293364: A Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema

Sponsor: Takeda. Phase: NA. Conditions: Hereditary Angioedema (HAE)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06575309: THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin

Sponsor: University Hospital, Clermont-Ferrand. Phase: . Conditions: Pregnant Women, Venous Thromboembolic Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT05549609: A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers

Sponsor: Xintela AB. Phase: PHASE1. Conditions: Venous Leg Ulcer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05965609: Optimizing Sleep Health in Nurses

Sponsor: Oregon State University. Phase: NA. Conditions: Circadian Rhythm Sleep-Wake Disorders, Shift Work Type, Sleep Initiation and Maintenance Disorders

full page →ctgov ↗
›COMPLETEDphase readoutNCT04741009: Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing

Sponsor: Cochlear. Phase: NA. Conditions: Sensorineural Hearing Loss, Low-Frequency Residual Hearing

full page →ctgov ↗
›COMPLETEDphase readoutNCT07049809: Targeting Sarcopenia and Frailty: Multicomponent Exercise With Focal Muscle Vibration

Sponsor: Universitat Internacional de Catalunya. Phase: NA. Conditions: Sarcopenia, Frailty at Older Adults, Cognitive Impairment, Adherence

full page →ctgov ↗
›RECRUITINGphase readoutNCT05147909: Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity

Sponsor: University of Texas Southwestern Medical Center. Phase: NA. Conditions: Physical Inactivity, Phosphate Overload, Visceral Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT06039709: Sonodynamic Therapy in Patients With Recurrent GBM

Sponsor: Shayan Moosa, MD. Phase: PHASE1. Conditions: Recurrent Glioblastoma, Glioblastoma Multiforme, GBM

full page →ctgov ↗
›RECRUITINGphase readoutNCT07393009: BIO|STREAM.CSP Study

Sponsor: Biotronik SE & Co. KG. Phase: . Conditions: Cardiac Pacing, Cardiac Pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy Devices, Bradycardia, Tachycardia, Heart Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07138209: A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma

Sponsor: Qilu Pharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Relapsed or Refractory Multiple Myeloma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06457009: Impact of Multi-Component Intervention on Suspected Asthma Population

Sponsor: Peking Union Medical College. Phase: NA. Conditions: Multimorbidity, Chronic Asthma, Population Medicine

full page →ctgov ↗
›COMPLETEDphase readoutNCT05847309: Early vs Delayed Extubation After Endovascular Treatment for Acute Ischemic Stroke

Sponsor: Hospital Clinico Universitario de Santiago. Phase: NA. Conditions: Acute Ischemic Stroke, Endovascular Treatment

full page →ctgov ↗
›COMPLETEDphase readoutNCT02055209: Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST)

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Hypertension

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06384599: VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study

Sponsor: Adagio Medical. Phase: NA. Conditions: Ventricular Tachycardia

full page →ctgov ↗
›COMPLETEDphase readoutNCT07342699: Location-Molecular Integrated Outcomes in 450 Cerebellar Glioma Microsurgical Cases

Sponsor: West China Hospital. Phase: . Conditions: Gliomas

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00840853: Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT

Sponsor: Baylor College of Medicine. Phase: PHASE1. Conditions: Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Non Hodgkin's Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT00093353: N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Sponsor: New Approaches to Neuroblastoma Therapy Consortium. Phase: PHASE1. Conditions: Diarrhea, Drug/Agent Toxicity by Tissue/Organ, Neuroblastoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT03906253: Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia

Sponsor: Wright State University. Phase: NA. Conditions: Actinic Keratoses, Aging, Non-Melanoma Skin Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07559253: Implementation of an Accessible Healthcare Model (ACHD STRONG): Comparing Nurse and Physician Lead Healthcare Transition Education in a RE-AIM Framework

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Congenital Heart Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT03617237: Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation

Sponsor: University of Texas Southwestern Medical Center. Phase: . Conditions: Cancer

full page →ctgov ↗
›TERMINATEDphase readoutNCT04085237: ESP Block for Laparoscopic Nephrectomy Surgeries

Sponsor: McMaster University. Phase: NA. Conditions: Kidney Cancer, Post-surgical Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07672145: Comparison of Gallbladder Extraction Via Subxiphoid vs Infraumbilical Port in Laparoscopic Cholecystectomy

Sponsor: King Edward Medical University. Phase: NA. Conditions: Cholelithiasis (Without Cholecystitis), Cholecystitis, Acute

full page →ctgov ↗
›COMPLETEDphase readoutNCT07426445: CLINICAL PERFORMANCE OF PEDIATRIC CROWNS IN PRIMARY MOLAR

Sponsor: Izmir Katip Celebi University. Phase: NA. Conditions: Dental Caries in Primary Teeth, Full-Coverage Restorations in Pediatric Dentistry

full page →ctgov ↗
›COMPLETEDphase readoutNCT04873245: Lifestyle Counseling and Medication for Adolescent Weight Management

Sponsor: University of Minnesota. Phase: PHASE2. Conditions: Obesity, Childhood

full page →ctgov ↗
›RECRUITINGphase readoutNCT05651945: Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)

Sponsor: Hackensack Meridian Health. Phase: NA. Conditions: Stroke, Cerebrovascular Accident

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07716072: Home Play-based Intervention for Parents and Infants

Sponsor: Nanyang Technological University. Phase: NA. Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD), Autism Spectrum Disorder, Premature Birth, Global Developmental Delay

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06882772: Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids

Sponsor: University of Nebraska. Phase: PHASE1. Conditions: Congenital Heart Disease (CHD)

full page →ctgov ↗
›TERMINATEDphase readoutNCT01851395: Rapid Autopsy and Procurement of Cancer Tissue

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Thymus Tumors, Adoptive Cellular Therapy, Mesothelioma, Genitourinary Cancers, Lung Cancers

full page →ctgov ↗
›TERMINATEDphase readoutNCT05956795: Surveillance of Regional Nodal Basins in Patients With Primary High Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck

Sponsor: Johns Hopkins University. Phase: . Conditions: Cutaneous Squamous Cell Carcinoma of the Head and Neck

full page →ctgov ↗
›COMPLETEDphase readoutNCT07716839: Effects of a Buriti Suplpement on Body Composition and Function in Older Adults

Sponsor: Federal University of Minas Gerais. Phase: NA. Conditions: Aging, Sarcopenia, Malnutrition Elderly

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07585539: Influence of the Primary Stability and Temporary Prosthetics

Sponsor: Tomas Linkevicius. Phase: NA. Conditions: Immediate Dental Implant Placement, Immediate Dental Implant Loading, Marginal Bone Levels

full page →ctgov ↗
›COMPLETEDphase readoutNCT06432439: Impact of Microneedling on Coverage of RT1 Gingival Recession in Thin Phenotype.

Sponsor: Postgraduate Institute of Dental Sciences Rohtak. Phase: NA. Conditions: Gingival Recession, Localized

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07342439: Study of Serine Supplementation to Protect Vision in MacTel

Sponsor: The Lowy Medical Research Institute Limited. Phase: PHASE3. Conditions: Macular Telangiectasia Type 2 (MacTel)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03233139: Safety and Pharmacokinetics of Cemiplimab Anti-programmed Death-ligand 1 (Anti-PD-1) and Other Agents in Japanese Adult Patients With Advanced Malignancies

Sponsor: Regeneron Pharmaceuticals. Phase: PHASE1. Conditions: Advanced Malignancies

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07436377: THE RELATİONSHİP BETWEEN BLOOD GAS PARAMETERS OBTAİNED FROM THE CORONARY SİNUS DURİNG THE PROCEDURE AND CRT RESPONSE İN PATİENTS WİTH HEART FAİLURE WHO UNDERWENT CRT IMPLANTATİON

Sponsor: Trakya University. Phase: . Conditions: Heart Failure, Cardiac Resynchronization Therapy, Coronary Sinus

full page →ctgov ↗
›COMPLETEDphase readoutNCT07588477: Functional Effects of Tendon Neuroplastic Training in Wrestlers

Sponsor: Hacettepe University. Phase: NA. Conditions: Shoulder Tendinopathy

full page →ctgov ↗
›COMPLETEDphase readoutNCT06173375: Head to Head Pilot Trial of Mailed Cologuard to Mailed FIT

Sponsor: University of California, San Diego. Phase: NA. Conditions: Colorectal Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07368257: Replication and Evaluation of the RISE-APS Model In New Contexts

Sponsor: RISE Collaborative. Phase: NA. Conditions: Elder Abuse, Self-Neglect

full page →ctgov ↗
›RECRUITINGphase readoutNCT07251257: The Seafarers' Continuous Glucose Monitoring Systems Study

Sponsor: University of Surrey. Phase: . Conditions: Insulin Dependent Diabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT03626857: MiACLR: Michigan Initiative for Anterior Cruciate Ligament Rehabilitation

Sponsor: University of Michigan. Phase: NA. Conditions: Anterior Cruciate Ligament Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT06809101: Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries.

Sponsor: Pomeranian Medical University Szczecin. Phase: . Conditions: Cancer, Cancer-related Problem/Condition, Chemotherapy, Chemotherapy-induced Neutropenia, Chemotherapy Induced Anaemia, Chemotherapy Induced Thrombocytopenia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07351812: Two Treatment Modalities for Myogenous Temporomandibular Disorders

Sponsor: Alexandria University. Phase: NA. Conditions: TMD

full page →ctgov ↗
›RECRUITINGphase readoutNCT06989112: DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Endometrial Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07459712: Pharmacokinetics and Pharmacodynamics of THS With LEVIA Compared to THS With TEREA and to Cigarettes

Sponsor: Philip Morris Products S.A.. Phase: NA. Conditions: Nicotine

full page →ctgov ↗
›COMPLETEDphase readoutNCT00932412: The CLARA Study From the Acute Leukemia French Association (ALFA 0702 Trial)

Sponsor: Hospices Civils de Lyon. Phase: PHASE2. Conditions: Acute Myeloid Leukemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06883812: Continuous Glucose Monitoring in Prediabetes With Health Education Videos Among Community Health Workers

Sponsor: David S Black, PhD. Phase: NA. Conditions: Prediabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT07275112: Cross-cultural an Reliability and Validity Evaluation of TENDINS-A in Spain

Sponsor: Cardenal Herrera University. Phase: . Conditions: Achilles Tendinopathy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07151612: The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia

Sponsor: Shanxi Eye Hospital. Phase: PHASE4. Conditions: Presbyopia

full page →ctgov ↗
← prev
page 107 of 107
next →